Sequent Scientific consolidates residual stake in Evance Group

12 Jan 2022 Evaluate

Sequent Scientific, having businesses in animal health sector through its principal operating company ‘Alivira Animal Health’ (Alivira), has completed consolidation of its Brazilian operations by increasing its shareholding in Evance Group to 100% for an effective consideration of Rs 44.6 crore.

This consolidation of Evance Group further builds on Alivira’s strong track record of successfully acquiring and integrating into its global businesses. The company, in the last fiscal successfully completed the 100% consolidation of Provet in Turkey, Fendigo BV and Fendigo SA in Europe.

Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.

Sequent Scientific Share Price

199.65 -8.00 (-3.85%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×